What is lorcaserin?

lorcserin hydrochloride is a drug designed for weight loss and weight control in obese patients. Diet pill is an agonist and anorectic receptor serotonin 2C (5-HT2C). In 2009, Arena submitted a Pharmaceuticals application for Lorcaserin Hydrochloride in American food and drug administration (FDA). In October 2010, the FDA rejected Lorcaserin in its form at that time and quoted concerns about the efficiency and links to cancer tumors in laboratory rats. The proposed trademark name was then Lorqess®. As agonist serotonin 2c, lorcaserin activates these receptors and produces chemicals that suppress hunger. The patient taking lorcserin feels fully faster, eats less calories and loses weight again. obesity) and a flowerY (behavioral modifications and the second study of lorcaserin for obesity management). These double blind clinical studies evaluated a weight loss pill for two years, with both groups also received food and exercise counseling.

Results for 3,182 patients were published in New England Journal of Medicine in July 2010. The authors reported that 47.5 percent of the Lorcaserin group lost 5 percent or more their body weight compared to 20.3 percent of the Placebo Group. Of those patients with weight loss who remained for lorcaserin, 67.9 percent Majasadil weight loss for one year. Without a diet pill, only 50.3 percent maintained the previous weight loss. The most commonly reported side effects included headaches, dizziness and nausea.

As the serotonin 2C receptor agonist, Lorqess® is similar to the forbidden penfluramine or Fen-Phen. Arena PharmaceuticaHowever, LS states that Lorqess® showed none of the phenfluramin toxic effects of the heart in clinical trials; LORCASERIN LORCserin receptor selectivity. The Pharmaceuticals Arena continued to work at the end of 2010 with the FDA for Lorqess® approval. He was also looking for a drug approval in Europe.